Send Inquiry

Request To Call Back

140 MG Ibrutinib Capsules

Get a Price/Quote

MOQ : 100 Packs

140 MG Ibrutinib Capsules Specification

Salt Composition
Ibrutinib 140 mg

Indication
Used to treat certain types of cancers such as Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenstrms Macroglobulinemia

Dosage Form
Capsule

Feature
Oral targeted therapy, BTK inhibitor

Ingredients
Ibrutinib and excipients

Application
Oncology / Cancer treatment

Physical Color/Texture
Opaque white to off-white capsule

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from light and moisture

Shelf Life
24 months

Drug Class
Brutons Tyrosine Kinase (BTK) Inhibitor

Brand Name
Varies (as per manufacturer)

Side Effects
Diarrhea, bleeding, infection, low blood cell counts

Prescription/Non prescription
Prescription only

Packaging Size
30 capsules per bottle

Route of Administration
Oral

Contraindications
Hypersensitivity to Ibrutinib

Strength
140 mg per capsule

140 MG Ibrutinib Capsules Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About 140 MG Ibrutinib Capsules

Unlock a peerless advancement in oncology care with our Fresh 140 MG Ibrutinib Capsules, boasting a top-ranking strength of 140 mg per capsule. Specially formulated as an oral, prescription-only targeted therapy, these elite capsules are designed for export, supply, and trading in India. Encased in hygienic, opaque white, odorless capsules, each bottle contains 30 units. As a Bruton's Tyrosine Kinase (BTK) inhibitor, Ibrutinib is essential in the fight against Mantle Cell Lymphoma, CLL, and Waldenstrom's Macroglobulinemia. Handle with care, store below 30C, and avoid use in individuals hypersensitive to Ibrutinib.

Diverse Applications & Usage of 140 MG Ibrutinib Capsules

140 MG Ibrutinib Capsules serve a vital role in oncology, offering oral targeted therapy for a spectrum of blood cancers. While primarily indicated for conditions like Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenstrom's Macroglobulinemia, these capsules also support combination therapy and advanced treatment regimens. Their usage spans top-tier hospitals, specialized cancer centers, and pharmaceutical distributors, ensuring a broad application in clinical oncology and research environments.

Export Markets, Payment & Dispatch for Ibrutinib Capsules

Our 140 MG Ibrutinib Capsules are in demand across elite international markets. We ensure secure packing & dispatch, primarily from leading Indian FOB Ports. Each consignment is meticulously prepared and dispatched promptly upon confirmation of the proposal amount and payment terms. Global clients benefit from flexible payment solutions, timely shipping, and compliant documentation, making us a preferred exporter, supplier, and trader of top-quality oncology medicines.

FAQ's of 140 MG Ibrutinib Capsules:

Q: How should 140 MG Ibrutinib Capsules be administered for optimal benefit?

A: 140 MG Ibrutinib Capsules are administered orally, once daily, exactly as prescribed by your healthcare provider to maximize therapeutic outcomes. Consistent timing is important for effectiveness.

Q: What are the primary medical uses of Ibrutinib 140 MG Capsules?

A: These capsules are primarily used to treat Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), and Waldenstrom's Macroglobulinemia, as well as contributing to combination therapies in certain cases.

Q: When should I avoid using Ibrutinib capsules?

A: You should avoid taking Ibrutinib if you have a known hypersensitivity to the active ingredient or if otherwise advised by your physician, considering its specific contraindications.

Q: Where are Ibrutinib 140 MG Capsules supplied or exported from?

A: Our Ibrutinib capsules are exported and supplied from India, usually via leading FOB ports, with strict adherence to international quality and regulatory standards.

Q: What is the process for packing and dispatching orders?

A: Orders are securely packed in climate-controlled environments and dispatched after proposal amount confirmation, ensuring the capsules remain stable and effective during transit.

Q: What side effects should patients be aware of when using Ibrutinib?

A: Patients may experience diarrhea, bleeding, infection, and low blood cell counts while on Ibrutinib. It is important to report any unusual symptoms to a healthcare provider immediately.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in Anti-Cancer Medicine Category

400 MG Daratumumab Concentrate For Solution For Infusion

Price 45000 INR / Vial

Minimum Order Quantity : 100 Vials

Salt Composition : Daratumumab 400 mg

Indication : Multiple myeloma (treatment of adult patients with multiple myeloma)

Feature : Other

Shelf Life : 24 months (unopened vial under recommended conditions) Months

Get a Price/Quote

Nivolumab Injection

Price 90000 INR / Vial

Minimum Order Quantity : 100 Vials

Salt Composition : Nivolumab

Indication : Treatment of advanced melanoma, nonsmall cell lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma and other cancers.

Feature : Other

Shelf Life : 24 months Months

Get a Price/Quote

50 MG Pembrolizumab For Injection

Minimum Order Quantity : 100 Packs

Salt Composition : Pembrolizumab 50 mg

Indication : Used in the treatment of certain cancers such as melanoma, nonsmall cell lung cancer, head and neck cancer, classical Hodgkin lymphoma, and urothelial carcinoma

Feature : Other, Sterile, preservativefree, and singleuse vial

Shelf Life : 24 Months

Get a Price/Quote